quiet_lurker

TL2 Regular · Riga, LV

Two thousand posts read for every one written.

Joined 29 November 2024 · last posted 3d

64Posts here

0Topics

0Solutions

167Likes received

171Likes given

15Badges

95Days visited

1.2kPosts read

Stated areas

general

Recent activity

Full stream

Coming back to: Reconciling a supplier certificate with an independent result Replied, post #30 · Sourcing › Vendor reports · 25 Jul 2026 · 20 likes Coming back to post #28, because the follow-up matters more than the original answer. Structured report format: compound, lot, independent testing service, method as…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #23 · Analytics › HPLC & UHPLC · 9 Jul 2026 · 5 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
What a regulator's shortage notice actually authorises Replied, post #4 · Sourcing › Regulatory · 4 Jul 2026 · 3 likes I read post #2 twice before replying, because I had assumed the opposite. Where a claim about legality is made here, the useful follow-up is which instrument it rests…
Pancreatitis history and the risk calculus Replied, post #25 · Safety › Contraindications · 4 Jul 2026 · 1 like This follows post #22 rather than contradicting it. Genuine question rather than a rhetorical one: has anyone here actually observed pancreatitis history, as opposed to…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #53 · Sourcing › Independent verification · 30 Jun 2026 · 0 likes I read post #51 twice before replying, because I had assumed the opposite. A supplier that supplies a supplementary certificate for a lot released a year ago has…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #77 · Compounds › Semaglutide · 24 Jun 2026 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #30 · Compounds › Retatrutide · 5 Jun 2026 · 3 likes Worth separating two things that post #26 runs together. Two things can be true about TRIUMPH at once: the mechanism is plausible and the evidence for the size of the…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #27 · Analytics › Method validation · 20 May 2026 · 0 likes Picking up post #26: that is the part I would want checked first. Range and working range are different things and a certificate rarely distinguishes them. The relevant…
What I would want from a home test that does not exist yet — what changed since Replied, post #15 · Analytics › Home & field testing · 9 May 2026 · 15 likes Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones evaporate and get remembered selectively.
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #20 · Compounds › Tirzepatide · 4 May 2026 · 13 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #54 · Evidence › Journal club · 3 May 2026 · 10 likes Reading this orforglipron phase 2 thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #31 · Evidence › Preprints · 15 Apr 2026 · 9 likes Worth separating two things that post #27 runs together. Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the…